Home > Healthcare > Healthcare IT > Artificial Intelligence > artificial intelligence in precision medicine market
Get a free sample of Artificial Intelligence in Precision Medicine Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Artificial Intelligence in Precision Medicine Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Rising adoption of artificial intelligence in healthcare research areas is expected to be a significant growth factor for the market. Researchers and healthcare professionals are increasingly recognizing the potential of AI in revolutionizing the way diseases are understood, diagnosed, and treated, thereby fostering the market revenue. Moreover, AI technologies such as machine learning and deep learning are being utilized to analyse vast amounts of medical data and identify patterns, correlations, and insights that can drive precision medicine approaches. This adoption of AI in research areas enables faster and more accurate data analysis, leading to advancements in disease understanding, drug discovery, and personalized treatment development.
AI in precision medicine market size reached USD 1.2 billion in 2022 and will amass USD 17.1 billion by 2032 driven by the rising R&D investments and the surging need for personalized medications
The software component segment held 53.4% of the artificial intelligence in precision medicine industry share in 2022 due to higher adoption of AI-based software solutions by healthcare institutions, payers, patients, and providers
AI in precision medicine market size from oncology applications may record USD 5.7 billion by end of 2032 owing to the rising prevalence of cancer cases and the increasing complexity of genomic data
North America recorded 51.9% of the artificial intelligence in precision medicine industry share in 2022 due to the growing frequency of cancer, cardiovascular conditions, and respiratory disorders